Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23155334 | 0.93 | KDM4E (0.31) | DNMT1 | |
| SCHEMBL21141018 | 0.92 | PDK2 (0.33) | PDK2SIGMAR1 | |
| SCHEMBL21392623 | 0.91 | SIGMAR1 (0.35) | PDK2SIGMAR1 | |
| SCHEMBL20762839 | 0.90 | PDK2 (0.33) | PDK2SIGMAR1 | |
| SCHEMBL23155369 | 0.89 | PDK2 (0.32) | DNMT1PDK2SIGMAR1 | |
| SCHEMBL19165668 | 0.89 | SIGMAR1 (0.35) | PDK2SIGMAR1 | |
| SCHEMBL19165443 | 0.89 | SIGMAR1 (0.35) | PDK2SIGMAR1 | |
| SCHEMBL19167386 | 0.89 | SIGMAR1 (0.35) | PDK2SIGMAR1 | |
| SCHEMBL23597862 | 0.88 | SIGMAR1 (0.35) | PDK2SIGMAR1 | |
| SCHEMBL808072 | 0.88 | SIGMAR1 (0.35) | PDK2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11594684-B2 | Condensed-cyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-02-28 | — | — | US | disclosed |
| US-20210098700-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11594684-B2 | Condensed-cyclic compound and organic light emitting device including the same | CRY1, SMCHD1, CXCR1 | DNMT1 1952/4885PDK2 2438/4885SIGMAR1 1167/4885 |
| US-20210098700-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, SMCHD1, CXCR1 | DNMT1 1952/4885PDK2 2438/4885SIGMAR1 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.